Neuropsychiatric Aspects of Infectious Diseases

Critical Care Clinics

Volumn 24, Issue 4, 2008, Pages 889-919

  Ferrando, Stephen J ^a   Freyberg, Zachary ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALPHA2A INTERFERON; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; DEXAMPHETAMINE; DIDANOSINE; EFAVIRENZ; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LORAZEPAM; METHYLPHENIDATE; MODAFINIL; NEVIRAPINE; OLANZAPINE; OXCARBAZEPINE; PEGINTERFERON ALPHA2A; PEMOLINE; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; UNINDEXED DRUG; VALPROIC ACID; ZIDOVUDINE; ZIPRASIDONE;

ACNE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGRANULOCYTOSIS; AKATHISIA; ANTISOCIAL BEHAVIOR; ANXIETY; ANXIETY DISORDER; ATAXIA; AUTOIMMUNE DISEASE; BIPOLAR DISORDER; BLOOD TOXICITY; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CREUTZFELDT JAKOB DISEASE; CRITICAL ILLNESS; DELIRIUM; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; EJACULATION DISORDER; ELECTROENCEPHALOGRAM; ENERGY; EXTRAPYRAMIDAL SYMPTOM; FACIAL EXPRESSION; FATIGUE; HAIR LOSS; HEPATITIS C; HERPES SIMPLEX ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; INTENSIVE CARE; IRRITABILITY; LUMBAR PUNCTURE; LYME DISEASE; MANIA; MENTAL DISEASE; NEUROCYSTICERCOSIS; NEUROPSYCHIATRY; NEUROSYPHILIS; NIGHTMARE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSIS; REVIEW; RIGIDITY; SEDATION; SIDE EFFECT; SLEEP DISORDER; STREPTOCOCCUS INFECTION; SUBSTANCE ABUSE; SUICIDAL IDEATION; TENSION; TESTIS ATROPHY; TREMOR; UNSPECIFIED SIDE EFFECT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; COMMUNICABLE DISEASES; DELIRIUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV-1; HUMANS; MALE; MENTAL DISORDERS; PREVALENCE;

EID: 53249132731     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.05.007     Document Type: Review

References (98)

1. Fleishman J.A., and Hellinger F.J. Trends in HIV-related inpatient admissions from 1993-1997: a seven-state study. J Acquir Immune Defic Syndr 28 (2001) 73-80
2. Fleishman J.A., and Hellinger F.H. Recent trends in HIV-related inpatient admissions 1996-2000: a seven-state study. J Acquir Immune Defic Syndr 34 (2003) 102-110
3. Paul S., Gilbert H.M., Lande L., et al. Impact of antiretroviral therapy on decreasing hospitalization rates of HI-infected patients in 2001. AIDS Res Hum Retroviruses 18 (2002) 501-506
4. Cebo K.A., Diener-West M., and Moore R.D. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 27 (2003) 143-152
5. Ferrando S., and Tiamson M. HIV disease. In: Blumenfield M., and Strain J.J. (Eds). Psychosomatic medicine (2006), Lippincott Williams and Wilkins, Philadelphia 277-296
6. Perry S., and Tross S. Psychiatric problems of aids inpatients at the New York Hospital: preliminary report. Public Health Rep 99 (1984) 200-205
7. Dilley J.W., Ochitill H.N., Perl M., et al. Findings in psychiatric consultations with patients with acquired immune deficiency syndrome. Am J Psychiatry 142 (1985) 82-86
8. O'Dowd M.A., and McKegney F.P. AIDS patients compared with others seen in psychiatric consultation. Gen Hosp Psychiatry 12 (1990) 50-55
9. Bialer P., Wallack J., Prenzlauer S., et al. Psychiatric comorbidity among hospitalized AIDS patients vs. non-AIDS patients referred for psychiatric consultation. Psychosomatics 37 (1996) 469-475
10. Ferrando S.J., Rabkin J., and Rothenberg J. Psychiatric disorders and adjustment of HIV and AIDS patients during and after medical hospitalization. Psychosomatics 39 (1998) 214-215
11. American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type-1 (HIV-1) infection. Neurology 41 (1991) 778-785
12. Antinori A., Arendt G., Becker J.T., et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69 (2007) 1789-1799
13. Sacktor N.C., Bacellar H., Hoover D.R., et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 2 (1996) 404-410
14. Wilkie F.L., Goodkin K., Eisdorfer C., et al. Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Neurosci 10 (1998) 125-132
15. Tozzi V., Balestra P., Serriano D., et al. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses 21 (2005) 706-713
16. Anthony I.C., and Bell J.E. The neuropathology of AIDS. Int Rev Psychiatry 20 (2008) 15-24
17. Smit T.K., Brew B.J., Tourtellotte W., et al. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol 78 (2004) 10133-10148
18. Letendre S., Marquie-Beck J., Capparelli E., et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65 (2008) 65-70
19. Sacktor N., Lyles R.H., Skolasky R., et al. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998. Neurology 56 (2001) 257-260
20. Filippi C., Sze G., Farber S.J., et al. Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. Radiology 206 (1998) 491-498
21. Sacktor N., Skolasky R.L., Ernst T., et al. A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging 21 (2005) 325-333
22. Tozzi V., Balestra P., Galgani S., et al. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13 (1999) 1889-1897
23. Ferrando S.J., Rabkin J.G., van Gorp W.G., et al. Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. J Neuropsychiatry Clin Neurosci 15 (2003) 208-214
24. Ferrando S., van Gorp W., McElhiney M., et al. Highly active antiretroviral treatment (HAART) in HIV infection: benefits for neuropsychological function. AIDS 12 (1998) F65-F70
25. Robertson K.R., Smurzynski M., Parsons T., et al. The Prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21 (2007) 1915-1921
26. Hinkin C.H., Hardy D.J., Mason K.L., et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status and substance abuse. AIDS 18 Suppl 1 (2004) S19-S25
27. van Gorp W.G., Rabkin J.G., Ferrando S.J., et al. Neuropsychiatric predictors of return to work in HIV/AIDS. J Int Neuropsychol Soc 13 (2007) 80-89
28. Perry S., Jacobsberg L.B., Fishman B., et al. Psychiatric diagnosis before serological testing for the human immunodeficiency virus. Am J Psychiatry 147 (1990) 89-93
29. Williams J.B.W., Rabkin J.G., Remien R.H., et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry 48 (1991) 124-130
30. Crone C., and Gabriel G.M. Comprehensive review of hepatitis C for psychiatrists: risks, screening, diagnosis, treatment and interferon-based therapy complications. J Psychiatr Pract 9 (2003) 93-110
31. Maxwell S., Scheftner W.A., Kessler H.A., et al. Manic syndrome associated with zidovudine treatment. JAMA 259 (1988) 3406-3407
32. Brouillette M.J., Chouinard G., and Laloonde R. Didanosine-induced mania in HIV infection. Am J Psychiatry 151 (1994) 1839-1840
33. Foster R., Taylor C., and Everall I.P. More on abacavir-induced neuropsychiatric reactions. AIDS 18 (2004) 2449
34. Morlese J.F., Qazi N.A., Gazzard B.G., et al. Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?. AIDS 16 (2002) 1840-1841
35. Staszewski S., Morales-Ramirez J., Tashima K.T., et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in treatment of HIV-1 infection in adults. Study 006 team. N Engl J Med 341 (1999) 1865-1873
36. Chen F., Day S.L., Metcalfe R.A., et al. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 84 (2005) 98-106
37. Mylonakis E., Koutkia P., and Grinspoon S. Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women. Clin Infect Dis 33 (2001) 857-864
38. Mayo J., Callazos J., Martinez E., et al. Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med 162 (2002) 1095-1098
39. Mierlak D., Leon A., and Perry S. Does physical improvement reduce depressive symptoms in HIV-infected medical inpatients?. Gen Hosp Psychiatry 17 (1995) 380-384
40. Rabkin J.G., Williams J.B., Remien R.H., et al. Depression, distress, lymphocyte subsets and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry 48 (1992) 111-119
41. Ferrando S.J., Goldman J.G., and Charness W. SSRI treatment of depression in symptomatic HIV infection and AIDS: improvements in affective and somatic symptoms. Gen Hosp Psychiatry 19 (1997) 89-97
42. Holmes V.F., Fernandez F., and Levy J.K. Psychostimulant response in AIDS-related complex patients. J Clin Psychiatry 50 (1989) 5-8
43. Wagner G.J., and Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial. J Clin Psychiatry 61 (2000) 436-440
44. Breitbart W., Rosenfeld B., Kaim M., et al. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med. 161 (2001) 411-420
45. Rabkin J.G., McElhiney M., Rabkin R., et al. Modafinil treatment of fatigue in HIV+ patients. J Clin Psychiatry 65 (2004) 1688-1695
46. Breitbart W., Marotta R., Platt M.M., et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153 (1996) 231-237
47. Mijch A.M., Judd F.K., Lyketsos C.G., et al. Secondary mania in patients with HIV infection: are antiretrovirals protective?. J Neuropsychiatry Clin Neurosci 11 (1999) 475-480
48. Tanquary J. Lithium neurotoxicity at therapeutic levels in an AIDS patient. J Nerv Ment Dis. 181 (1993) 518-519
49. Halman M.H., Worth J.L., Sanders K.M., et al. Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 5 (1993) 430-434
50. McDaniel J.S., and for the Working Group on HIV/AIDS. Practice guideline for the treatment of patients with HIV/AIDS. Am J Psychiatry 157 (2000) 1-62
51. Sewell D.D., Jeste D.V., Atkinson J.H., et al. HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group. Am J Psychiatry 151 (1994) 237-242
52. Sewell D.D., Jeste D.V., McAdams L.A., et al. Neuroleptic treatment of HIV-associated psychosis. HNRC group. Neuropsychopharmacology 10 (1994) 223-229
53. Fernandez F., and Levy J.K. The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus. Case reports. Gen Hosp Psychiatry 15 (1993) 31-35
54. Lera G., and Zirulnik J. Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism. Mov Disord 14 (1999) 128-131
55. Singh A.N., Golledge H., and Catalan J. Treatment of HIV-related psychotic disorders with risperidone: a series of 21 cases. J Psychosom Res 42 (1997) 489-493
56. Meyer J.M., Marsh J., and Simpson G. Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient. Biol Psychiatry 44 (1998) 791-794
57. Arciniegas D.B., and Anderson C.A. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Curr Psychiatry Rep 6 (2004) 372-379
58. Chaudhuri A., and Kennedy P.G.E. Diagnosis and treatment of viral encephalitis. Postgrad Med J 78 (2002) 575-583
59. Hjalmarsson A., Blomqvist P., and Sköldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity and mortality. Clin Infect Dis 45 (2007) 875-880
60. Whitley R.J., and Gnann J.W. Viral encephalitis: familiar infections and emerging pathogens. Lancet 359 (2002) 507-514
61. Pavone P., Parano E., Rizzo R., et al. Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham's chorea, PANDAS, and PANDAS variants. J Child Neurol 21 (2006) 727-736
62. Schneider R.K., Robinson M.J., and Levenson J. Psychiatric presentations of non-HIV infectious diseases: neurocysticercosis, Lyme disease, and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection. Psychiatr Clin North Am 25 (2002) 1-16
63. Swedo S.E. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry 7 (2002) S24-S25
64. Perlmutter S.J., Garvey M.A., Castellanos X., et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 155 (1998) 1592-1598
65. Pavone P., Bianchini R., Parano E., et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 30 (2004) 107-110
66. Giedd J.N., Rapoport J.L., Garvey M.A., et al. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 157 (2000) 281-283
67. Perlmutter S.J., Leitman S.F., Garvey M.A., et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354 (1999) 1153-1158
68. Garvey M.A., Perlmutter S.J., Allen A.J., et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45 (1999) 1564-1571
69. Snider L.A., Lougee L., Slattery M., et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 57 (2005) 788-792
70. Del Brutto O.H. Neurocysticercosis. Semin Neurol 25 (2005) 243-251
71. Tavares A.R. Psychiatric disorders in neurocysticercosis. Br J Psychiatry 163 (1993) 839
72. Meza N.W., Rossi N.E., Galeazzi T.N., et al. Cysticercosis in chronic psychiatric inpatients from a Venezuelan community. Am J Trop Med Hyg 73 (2005) 504-509
73. Signore R.J., and Lahmeyer H.W. Acute psychosis in a patient with cerebral cysticercosis. Psychosomatics 29 (1988) 106-108
74. Nash T.E., Singh G., White A.C., et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 67 (2006) 1120-1127
75. Hutto B. Syphilis in clinical psychiatry: a review. Psychosomatics 46 (2001) 453-460
76. Conde-Sendín M.A., Amela-Peris R., Aladro-Benito Y., et al. Current clinical spectrum of neurosyphilis in immunocompetent patients. Eur Neurol. 52 (2004) 29-35
77. Sanchez F.M., and Zisselman M.H. Treatment of psychiatric symptoms associated with neurosyphilis. Psychosomatics 48 (2007) 440-445
78. Carmo R.A., Moura A.S., Christo P.P., et al. Syphilitic meningitis in HIV-patients with meningeal syndrome: report of two cases and review. Braz J Infect Dis 5 (2001) 280-287
79. Sobhan T., Rowe H.M., Ryan W.G., et al. Unusual case report: three cases of psychiatric manifestations of neurosyphilis. Psychiatr Serv 55 (2004) 830-832
80. Russouw H.G., Roberts M.C., Emsley R.A., et al. Psychiatric manifestations and magnetic resonance imaging in HIV-negative neurosyphilis. Biol Psychiatry 41 (1997) 467-473
81. Taycan O., Uǧur M., and Ozmen M. Quetiapine vs. risperidone in treating psychosis in neurosyphilis: a case report. Gen Hosp Psychiatry 8 (2006) 359-361
82. Turan S., Emul M., Duran A., et al. Effectiveness of olanzapine in neurosyphilis related organic psychosis: a case report. J Psychopharmacol 21 (2007) 556-558
83. Martindale J.L., Geschwind M.D., and Miller B.L. Psychiatric and neuroimaging findings in Creutzfeldt-Jakob disease. Curr Psychiatry Rep 5 (2003) 43-46
84. Caramelli M., Ru G., Acutis P., et al. Prion diseases: current understanding of epidemiology and pathogenesis and therapeutic advances. CNS Drugs 20 (2006) 15-28
85. Pederson N.S., and Smith E. Prion diseases: epidemiology in man. APMIS 110 (2002) 14-22
86. Spencer M.D., Knight R.S.G., and Will R.G. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324 (2002) 1479-1482
87. Wall C.A., Rummans T.A., Aksamit A.J., et al. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J Neuropsychiatry Clin Neurosci 17 (2005) 489-495
88. Moellentine C.K., and Rummans T.A. The varied neuropsychiatric presentations of Creutzfeldt-Jakob disease. Psychosomatics 40 (1999) 260-263
89. Jiang T.T., Moses H., Gordon H., et al. Sporadic Creutzfeldt-Jakob disease presenting as major depression. South Med J 92 (1999) 807-808
90. Jadri R., DiPaola C., Lajugie C., et al. Depressive disorder with psychotic symptoms as psychiatric presentation of sporadic Creutzfeldt-Jakob disease: a case report. Gen Hosp Psychiatry 28 (2006) 452-454
91. Kapur N., Abbot P., Lowman A., et al. The neuropsychological profile associated with variant Creutzfeldt-Jakob disease. Brain 126 (2003) 2693-2702
92. Wieser H.G., Schindler K., and Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 117 (2006) 935-951
93. Green A.J.E. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jacob disease. Biochem Soc Trans 30 (2002) 382-386
94. Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76 (2005) 906-919
95. Kaplan R.F., Trevino R.P., Johnson G.M., et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help?. Neurology 60 12 (2003) 1888-1889
96. Kaplan R.F., and Jones-Woodward L. Lyme encephalopathy: a neuropsychological perspective. Semin Neurol 17 (1997) 31-37
97. Oksi J., Kalimo H., Marttila R.J., et al. Inflammatory brain changes in Lyme borreliosis: a report on three patients and review of literature. Brain 119 (1996) 2143-2154
98. Logigian E.L., Johnson K.A., Kijewski M.F., et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 49 6 (1997) 1661-1670